John Martin is named as a lobbyist on federal disclosure filings for 39 clients through Capitol Counsel LLC. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs and Pharmacy.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| DAIMLER TRUCKS NORTH AMERICA | CAPITOL COUNSEL LLC | Q3 2026 | Transportation, Trade (domestic/foreign), Energy/Nuclear |
| AMERICAN PSYCHIATRIC ASSOCIATION | CAPITOL COUNSEL LLC | Q3 2026 | Medicare/Medicaid, Health Issues |
| BRISTOL-MYERS SQUIBB | CAPITOL COUNSEL LLC | Q3 2026 | Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Health Issues |
| MADRIGAL PHARMACEUTICALS, INC. | CAPITOL COUNSEL LLC | Q3 2026 | Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Health Issues |
| BIOTECHNOLOGY INNOVATION ORGANIZATION (FORMERLY BIOTECHNOLOGY INDUSTRY ORG.) | CAPITOL COUNSEL LLC | Q3 2026 | Trade (domestic/foreign), Medicare/Medicaid, Health Issues |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | CAPITOL COUNSEL LLC | Q3 2026 | Medicare/Medicaid |
| SHARE OUR STRENGTH | CAPITOL COUNSEL LLC | Q3 2026 | Agriculture, Taxation/Internal Revenue Code, Health Issues |
| JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS | CAPITOL COUNSEL LLC | Q3 2026 | Medicare/Medicaid, Health Issues, Veterans |
| IPSEN BIOPHARMACEUTICALS, INC. | CAPITOL COUNSEL LLC | Q3 2026 | Medicare/Medicaid |
| GENENTECH | CAPITOL COUNSEL LLC | Q3 2026 | Medicare/Medicaid, Health Issues |
| BAYER CORPORATION | CAPITOL COUNSEL LLC | Q3 2026 | Health Issues |
| AMGEN INC. | CAPITOL COUNSEL LLC | Q3 2026 | Medicare/Medicaid |
| AMERICAN BANKERS ASSOCIATION HSA COUNCIL | CAPITOL COUNSEL LLC | Q3 2026 | Taxation/Internal Revenue Code, Health Issues |
| AMERICAN ACADEMY OF DERMATOLOGY | CAPITOL COUNSEL LLC | Q3 2026 | Medicare/Medicaid, Health Issues |
| L'OREAL USA S/D, INC. | CAPITOL COUNSEL LLC | Q3 2026 | Health Issues |
| MARCH OF DIMES INC. | CAPITOL COUNSEL LLC | Q3 2026 | Health Issues |
| NEUROCRINE BIOSCIENCES, INC. | CAPITOL COUNSEL LLC | Q3 2026 | Medicare/Medicaid, Health Issues, Budget/Appropriations |
| GLAXOSMITHKLINE LLC | CAPITOL COUNSEL LLC | Q3 2026 | Medicare/Medicaid, Health Issues |
| HEALTHCARE LEADERSHIP COUNCIL | CAPITOL COUNSEL LLC | Q3 2026 | Medicare/Medicaid, Health Issues |
| EMD SERONO, INC. | CAPITOL COUNSEL LLC | Q3 2026 | Medicare/Medicaid, Pharmacy |
| CURIUM | CAPITOL COUNSEL LLC | Q3 2026 | Pharmacy |
| BLUE EARTH DIAGNOSTICS, INC. | CAPITOL COUNSEL LLC | Q3 2026 | Health Issues |
| ZAI LAB (US) LLC | CAPITOL COUNSEL LLC | Q3 2026 | Financial Institutions/Investments/Securities, Health Issues |
| TEMPUS LABS, INC. | CAPITOL COUNSEL LLC | Q3 2026 | Science/Technology, Medical/Disease Research/Clinical Labs, Medicare/Medicaid |
| NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) | CAPITOL COUNSEL LLC | Q3 2026 | Medicare/Medicaid, Health Issues |
| LUNDBECK PHARMACEUTICALS LLC | CAPITOL COUNSEL LLC | Q3 2026 | Medicare/Medicaid, Health Issues |
| GRANICUS, LLC | CAPITOL COUNSEL LLC | Q3 2026 | Computer Industry, Government Issues |
| BOEHRINGER INGELHEIM ANIMAL HEALTH US | CAPITOL COUNSEL LLC | Q3 2026 | Animals, Medical/Disease Research/Clinical Labs |
| AMERICAN PHYSICAL THERAPY ASSOCIATION | CAPITOL COUNSEL LLC | Q3 2026 | Health Issues |
| AMERICAN COLLEGE OF EMERGENCY PHYSICIANS | CAPITOL COUNSEL LLC | Q3 2026 | Labor Issues/Antitrust/Workplace, Health Issues |
| ALNYLAM PHARMACEUTICALS, INC. | CAPITOL COUNSEL LLC | Q3 2026 | Medical/Disease Research/Clinical Labs |
| FOODCORPS, INC. | CAPITOL COUNSEL LLC | Q2 2026 | Health Issues |
| DISC MEDICINE | CAPITOL COUNSEL LLC | Q2 2026 | Medicare/Medicaid, Health Issues |
| CONTINUUS PHARMACEUTICALS | CAPITOL COUNSEL LLC | Q2 2026 | Economics/Economic Development, Medicare/Medicaid, Health Issues |
| AMICUS THERAPEUTICS, INC. | CAPITOL COUNSEL LLC | Q2 2026 | Medicare/Medicaid, Health Issues |
| PCCA, INC. | CAPITOL COUNSEL LLC | Q1 2026 | Pharmacy |
| MEAD JOHNSON AND COMPANY, LLC | CAPITOL COUNSEL LLC | Q4 2025 | Food Industry (safety, labeling, etc.) |
| AMERICAN FOOTBALL COACHES ASSOCIATION | CAPITOL COUNSEL LLC | Q2 2025 | Sports/Athletics |
| RITE AID CORPORATION | CAPITOL COUNSEL LLC | Q1 2025 | Medicare/Medicaid, Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 36 | 1 |
| 2025 | 31 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 8 | $18K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name John Martin. See the Capitol Clarity rankings and method.